SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express strong bullish sentiment and highlight its consistent growth within the Solana ecosystem. Talk centers around the potential for a significant run, emphasizing community strength and long-term vision. The community is focused on the "We're all gonna make it" narrative.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as community members draw comparisons to the recent Beyond Meat surge, sparking discussions about potential short squeezes and the impact of meme stock dynamics. Investors are closely watching for upcoming news and potential catalysts, while also debating the influence of key figures like Ryan Cohen and Roaring Kitty on the stock's future trajectory. The community is actively discussing potential trading strategies amid high volatility and speculation.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending, with community members frequently mentioning "WAGMI" and "Pump". Hong Kong's approval of a Solana spot ETF by ChinaAMC appears to be a key catalyst, sparking discussions about potential price movements and broader crypto market trends. Some traders are also watching for breakouts above key resistance levels.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to a post-earnings dip, driven by a reported miss in EPS attributed to a one-time Brazilian tax issue, sparking debates about its valuation. The community is discussing potential downgrades and the impact on the broader market, while some view the dip as a buying opportunity, anticipating a rebound. Concerns about subscriber growth, content quality and production costs are also circulating.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

NERV is trending due to a recently announced financing deal of up to $200 million to advance its schizophrenia treatment, roluperidone, through Phase 3 trials, leading to significant price movement. The community is actively discussing key price levels and potential for continued upside, while some traders express caution regarding possible dilution or short selling. Overall sentiment suggests excitement around the funding milestone and potential FDA catalyst, balanced with awareness of potential risks.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around OG memes and a strong sense of community, emphasizing the value of holding and pushing for increased visibility. The community is actively working together, shunning traditional 'coining' and heralding a meme-driven market revival. Discussions include aiming for top trending spots and anticipation for future milestones.

GE Vernova, Inc. is a electric power industry. Its products and services generate, transfer, orchestrate, convert, and store electricity. The firm operates through the following segments: Power, Wind and Electrification. The Power segment includes design, manufacture, and servicing of gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. The Electrification segment includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The Company was founded November 09, 2021 and is headquartered in Cambridge, Massachusetts.

GE Vernova Inc.

GE Vernova is trending following strong earnings and raised guidance, driven by soaring electricity demand from AI data centers. Community members are discussing potential price targets and whether the stock is overvalued after its impressive run. Some analysts highlight the company's key role in meeting the growing power needs of AI infrastructure.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is trending downwards after a mixed Q3 earnings report and cautious guidance, prompting analyst downgrades and concerns about growth. The community is discussing whether this drop is an overreaction or signals fundamental weakness, focusing on the impact of tariffs and competition. Despite strong growth in some sectors, investors appear wary of the company's valuation and future prospects.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst discussions around Trump's potential influence and actions, including a recent request for funds from the DOJ. Community talking points revolve around the political implications and the stock's future performance. The conversations also touch on the broader economic landscape under different administrations.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending as investors debate whether the recent dip presents a buying opportunity or signals further decline, with some pointing to a potential AI sector rotation. Community members are closely watching support levels and anticipating upcoming earnings for a catalyst. The stock's volatility and recent red days have fueled discussions about its valuation and future growth potential amid broader market conditions.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Glass Lewis said that the approval of the compensation would lead to potential&nbsp;share dilution.</li><li>Last week, ISS also recommended voting against the $1 trillion pay package of CEO Elon Musk.</li><li>Tesla said in a post on X that ISS and Glass Lewis have recommended against Tesla’s proposals time and time again since the 2018 CEO Performance Award was introduced.</li></ul>Proxy adviser Glass Lewis has urged Tesla (TSLA) shareholders to vote against CEO Elon Musk's $1 trillion compensation package, joining Institutional Shareholder Services (ISS) to reject one of the largest salary packages of a company’s head.Glass Lewis stated that the approval of the compensation would lead to potential&nbsp;share&nbsp;dilution and other terms of the proposed pay plan "warrant significant concern,” according to TheFly.The recommendations by Glass Lewis and ISS come as part of wider voter guidance issued ahead of Tesla's annual shareholders meeting on November 6.Retail sentiment on <a href="https://stocktwits.com/symbol/TSLA">Tesla</a> remained unchanged in the ‘bearish’ territory compared to a day ago, with message volumes at ‘low’ levels, according to data from Stocktwits.<h2 class="st-heading-2">What Is Tesla’s Response?</h2>Tesla<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/Tesla/status/1980257694713098636">&nbsp;said in a X post</a> that ISS and Glass Lewis have recommended against the company’s proposals time and time again since the 2018 CEO Performance Award was introduced.“…Glass Lewis has followed ISS and issued another misguided recommendation that again disregards the fundamental purpose of public companies and who they serve – the shareholders. These firms do not own Tesla – you do,” the company added.Tesla said that the shortcomings of these proxy advisors are echoed by state and federal officials, who are scrutinizing ISS’s and Glass Lewis’s practices, including by implementing laws that require that their recommendations be based on the financial interests of shareholders.“ISS’s and Glass Lewis’s recommendations attempt to override the mandate our shareholders delivered to Elon and ignore the staggering financial results delivered under Elon’s leadership, elevating their rigid policies over shareholder value.,” Tesla said further in the post.<h2 class="st-heading-2">What Did ISS Say About The Pay Package?</h2>According to a Reuters report, ISS said that this was part of the board's goal to retain Musk because of his "track record and vision," the 2025 pay package "locks in extraordinarily high pay opportunities over the next ten years."&nbsp;ISS noted that his also "reduces the board's ability to meaningfully adjust future pay levels."The report added that ISS highlighted concerns over the proposed grant’s "astronomical" size, its structure allowing substantial payouts even with partial goal attainment, and the risk of diluting existing shareholders' equity.Shares of Tesla rose 1% in early trading on Monday and have more than doubled in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/molson-coors-announces-workforce-reduction/ch6CDuqR3Yp">Molson Coors Announces Workforce Reduction, Nearly 400 Salaried Positions To Be Eliminated</a>

Tesla Motors CEO Elon Musk speaks to the media next to its Model S during a press conference in Hong Kong. 25JAN16 SCMP/ Nora Tam (Photo by Nora Tam/South China Morning Post via Getty Images)

 Glass Lewis Urges Tesla Shareholders To Vote Against Elon Musk’s $1T Pay

Glass Lewis said that the approval of the compensation would lead to potential dilution to shareholders.

Equity

Carvana (CVNA) stock was one of the top trending tickers on Stocktwits after the company’s shares fell nearly 6% in afternoon trading, with recent bankruptcies of subprime lender Tricolor and auto supplier First Brands Group putting the focus on auto-related firms.BTIG maintained a ‘Buy’ rating and $450 price target on Carvana, according to TheFly. The firm noted that the company's September Asset-Backed Securities performance data for its closely-watched 2025-N1 issuance has shown signs of improvement as the pace of cumulative net loss development slowed and 30- and 60-day delinquencies declined.The firm said that while it sees the September numbers as "incrementally reassuring", the environment remains dynamic. Last week, BTIG had said that with the bankruptcy of Tricolor and CarMax adding more reserves to its loan portfolio, general macro concerns have brought renewed interest in Carvana's financing exposure.Retail sentiment on Carvana dipped to ‘bearish’ from ‘neutral’ territory compared to a day ago, with message volumes at ‘normal’ levels, according to Stocktwits data.Auto supplier First Brands Group, which went bankrupt in late September, has seen its creditors open probes amid concerns over potential financial irregularities.BTIG had further noted last week that it does not believe Carvana will lose access to the securitization markets regardless of whether past securitizations experience impairment to their equity tranche. While the firm is closely following credit across consumers, it continues to see the company's fundamental value drivers as intact,&nbsp;it said.<a href="https://stocktwits.com/symbol/CVNA">Shares of Carvana</a> have gained 60% this year and have jumped over 71% in the last 12 months.Get updates to this developing story directly on Stocktwits.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/jefferies-ceo-claims-bank-was-defrauded-by-bankrupt-auto-supplier-first-brands-group/ch6sKBzR38y">Jefferies CEO Claims Bank Was ‘Defrauded’ By Bankrupt Auto Supplier First Brands Group</a>

In this photo illustration, a person holds a smartphone displaying the logo of Carvana. (Photo illustration by Cheng Xin/Getty Images)

Carvana Stock In Spotlight After 6% Slide Today: BTIG Maintains ‘Buy’ Rating

BTIG said that the company's September Asset-Backed Securities performance data for its closely-watched 2025-N1 issuance has shown signs of improvement.

Amazon.com (AMZN) founder Jeff Bezos reportedly said that people should be thrilled about artificial intelligence (AI) and not discouraged about it.“I don’t see how anybody can be discouraged who is alive,” said Bezos, during a panel discussion at Italian Tech Week 2025 in October, according to a CNBC report.&nbsp;”[AI will make every business’] quality go up and their productivity go up ... Every manufacturing company, every hotel, every consumer products company ... That’s hard to fathom, but it’s real,” he said.According to the report, Bezos noted that different industries will all use AI at different rates, although he said he could not outline a timeline for this. He also said that AI is in an “industrial bubble,” presently with stocks trading at record highs and investors struggling to figure out “the good ideas and the bad ideas.”According to the CNBC report, Bezos said the “winners” from AI, who will use it to advance research and development irrespective of the industry, will provide “gigantic” benefits to society. “There’s never been a better time to be excited about the future,” he said.Retail sentiment on <a href="https://stocktwits.com/symbol/AMZN">Amazon</a> remained unchanged in the ‘bearish’ territory compared to a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits. Shares of Amazon have gained nearly 13% in the last 12 months.The report added that not many people agree with what Bezos expressed, according to Pew Research Center data, which was published on Wednesday. In a global survey, a median of 34% of adults told Pew they’re more concerned than excited about “the rise of AI in daily life.”According to Pew, 42% said they’re equally concerned and excited, and 16% said they’re more excited than concerned, the report stated. It noted that worries over AI are stronger in the U.S., where 50% of respondents told Pew they were more concerned than excited, and 38% said they were equally concerned and excited.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/oklo-stock-in-spotlight-after-announcing-2-b-nuclear-pact/ch6s9INR38K">Oklo Stock In Spotlight After Announcing $2B Pact For Advancing US Nuclear Fuel Ecosystem</a>

Jeff Bezos at The 11th Breakthrough Prize Ceremony held at Barker Hanger on April 05, 2025 in Santa Monica, California. (Photo by Gilbert Flores/Variety via Getty Images)

Jeff Bezos Reportedly Says People Should Be Thrilled About AI: ‘Don’t See How Anybody Can Be Discouraged Who Is Alive’

According to a CNBC report, Bezos noted that different industries will all use AI at different rates, although he said he could not outline a timeline for this.

Eli Lilly and Company (LLY) on Friday stated that two years of adjuvant Verzenio plus endocrine therapy reduced the risk of death by 15.8% as compared to endocrine therapy alone in a late-stage trial in patients with a certain type of high-risk early breast cancer.According to the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investor.lilly.com/news-releases/news-release-details/lillys-verzenior-abemaciclib-prolonged-survival-hr-her2-high">firm</a>, Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in this type of breast cancer.Furthermore, treatment with Verzenio plus endocrine therapy led to a sustained reduction in risk of recurrence at seven years, Lilly said. The company noted that 32% fewer patients treated with Verzenio plus ET were living with metastatic disease compared to those receiving ET alone after seven years.“Continued long-term follow-up from this trial will help to determine whether this ongoing difference in patients alive with metastatic disease translates into further deepening of survival benefit with time,” the company said.The data is being submitted to health authorities worldwide, the company said. Jacob Van Naarden, executive vice president and president of Lilly Oncology, termed the study results an “important advancement” in the care of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive, high-risk early breast cancer.Safety findings were consistent with the known profile of Verzenio, and adverse events were generally managed with dose modifications in the study, the company added.<a href="https://stocktwits.com/symbol/LLY">LLY shares</a> traded 4% lower in the pre-market session at the time of writing after President Trump <a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-novo-nordisk-stocks-fall-after-hours-trump-pledges-swift-price-cuts-for-fat-loss-drugs/ch6rwjbR3Fa">said</a> on Thursday that the price of its rival Novo Nordisk’s weight-loss drug would be lowered. On Stocktwits, retail sentiment around LLY stock stayed within the ‘bearish’ territory while message volume rose from ‘low’ to ‘high’ levels.LLY stock is up by 6% this year but has fallen 11% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/protalix-biotherapeutics-stock-tumbles-after-negative-chmp-opinion/ch6s74tR389">Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. (Photo by Scott Olson/Getty Images)

Eli Lilly Says Verzenio Reduced Risk of Death In Late-Stage Trial In Some Breast Cancer Patients

According to Lilly, Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in this type of breast cancer.

SoFi Technologies (SOFI) stock became the top trending ticker on Stocktwits on Friday morning and witnessed over a 60% increase in retail user message count in the last 24 hours after the company’s platform, Galileo Financial Technologies, announced it had joined the Amazon Web Services (AWS) partner network.The partnership is to expand access to Galileo Financial’s payment processing solutions. The company announced that businesses across various industries can now utilize Galileo’s platform on AWS to develop, deploy, and scale modern financial experiences.As an Amazon partner network member, Galileo joins a global network of 130,000 Partners from more than 200 countries working with AWS.“By joining the AWS Partner Network, we’re meeting businesses where they already are, making it faster and easier for them to access our financial technology and bring new financial products to their customers,” said Sandy Weil, Chief Revenue Officer at Galileo, SoFi’s Technology Platform.<a href="https://stocktwits.com/symbol/SOFI">Shares of SoFi Technologies</a> were down nearly 2% before the bell on Friday. Retail sentiment on the stock dipped to ‘bearish’ from ‘neutral’ territory compared to a day ago, with message volumes at ‘normal’ levels, according to data from Stocktwits.On Wednesday, Keefe Bruyette analyst Timothy Switzer raised the price target on SoFi Technologies to $18 from $14 and maintained an ‘Underperform’ rating, according to TheFly. The firm increased its estimates ahead of the company's third-quarter results on October 28 to reflect higher net interest income and momentum in the loan platform business.While "several positive potential catalysts" could bring support for the shares in the near term, SoFi's risk and reward "seems skewed negatively over the long term given the premium valuation," Switzer said.Shares of SoFi Technologies have jumped 73% this year and have gained over 161% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/american-express-stock-slips-ahead-of-q3-earnings/ch6sdiWR3Fx">American Express Stock Slips Ahead Of Q3 Earnings: Retail Sentiment Turns Bullish</a>

The SoFi Technologies, Inc. logo appears on a smartphone screen in this illustration photo in Reno, United States, on December 20, 2024.

SOFI Stock Is The Talk Of The Town Today, And There’s An Amazon Angle

Galileo Financial said that as an Amazon partner network member, it joins a global network of 130,000 partners from more than 200 countries working with AWS.

Apple’s (AAPL) Senior Vice President of Services Eddy Cue reportedly said that the sports streaming business needs fixing as the iPhone maker edges closer to securing Formula 1 rights.“We’ve gone backwards,” said Cue at the Motorsport Network’s Autosport Business Exchange&nbsp;NYC, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/10/16/apple-wants-to-reform-sports-streaming-as-it-nears-f1-rights-deal.html">according to a CNBC report</a>. “You used to buy one subscription, your cable subscription, and you got pretty much everything they had. Now, there’s so many different subscriptions, so I think that needs to be fixed,” Cue said during a panel&nbsp;discussion at the conference on Wednesday.The report noted that in some way, Apple could be a part of the problem as well. CNBC, citing people familiar with the matter, reported that Apple is&nbsp;set to announce its $140 million per year U.S. media rights deal with F1.Retail sentiment on Apple remained unchanged in the ‘bearish’ territory compared to a day ago, with message volumes at ‘low’ levels, according to data from Stocktwits. Shares of the company were down marginally in early trading.CNBC reported that with the F1 deal, Apple is expanding the sports line-up, which already features Major League Soccer and MLB’s “Friday Night Baseball.” An Apple TV subscription is priced at $12.99 per month.Cue noted that consumers can now access a wide variety of sports, a positive development compared to 10 or 20 years ago. However, they must sign up for “1,200 subscriptions” to do so. The solution to this, according to Cue, was “more bundling” and more partnership between media partners.“If I’m a league, and I have two partners, for example, it should be very easy for me to go between them and do all kinds of things between them and do picture-in-picture, but I can’t. And so I think that there are definitely solutions to some of these. It’s harder, but that’s why we’re all here,” Cue said at the conference, according to CNBC.<a href="https://stocktwits.com/symbol/AAPL">Shares of Apple</a> have gained nearly 7% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nestles-us-listed-shares-rally-on-plans-to-reduce-16-000-global-jobs/ch6p3LSR3np">Nestle’s US-listed Shares Rally On Plans To Reduce 16,000 Global Jobs Over Two Years</a>

Eddy Cue speaks during Autosport Business Exchange New York, a Motorsport Network event at Classic Car Club Manhattan on October 15, 2025 in New York City.

Apple’s Eddy Cue Pushes For Fixing Sports Streaming As Company Nears Formula 1 Rights Deal

According to a CNBC report, citing people familiar with the matter, Apple is set to announce its $140 million per year U.S. media rights deal with F1.

Alibaba’s (BABA) Vice President Kaifu Zhang reportedly told reporters on Thursday that the company was seeing a recovery from its artificial intelligence investment in the e-commerce operations.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/10/16/alibaba-says-ai-spending-for-e-commerce-taobao-tmall-is-breaking-even.html">CNBC report</a>, Zhang, who looks after the company’s e-commerce AI applications, shared that Alibaba deployed multiple AI tools aimed at boosting personalized user experience and also virtual try-ons of clothing. The report, citing Zhang, said that the initial testing has shown that AI has generated steady results with a 12% rise in advertising spend returns.“It’s very rare to see double-digit changes” in such tests, Zhang said in Mandarin and translated by CNBC. The report noted that he forecast a “very significant” positive impact mainly from the company’s AI investment, which will help boost Alibaba’s gross merchandise volume during the November 11 Singles Day shopping period.<a href="https://stocktwits.com/symbol/BABA">NYSE-listed shares of BABA</a> traded nearly 0.5% higher in Thursday’s pre-market session. Retail sentiment on Alibaba remained unchanged in the ‘bearish’ territory compared to a day ago, with message volumes at ‘normal’ levels, according to data from Stocktwits.The report said that research firm Syntun had forecast a 20.1% rise in sales to 1.11 trillion yuan ($155.75 billion), compared to a year ago, for Alibaba’s Tmall, JD.com and PDD during the Singles Day last year. This came at a time when consumer spending in China had been lull in the last few years.&nbsp;According to the CNBC report, Alibaba had noted during its last earnings that AI and consumption were “two major historic opportunities” making it a need to invest at a “historic scale” in these two.&nbsp;In September, a CNBC report cited CEO Eddie Wu saying, “We are vigorously advancing a three-year, 380 billion [yuan] AI infrastructure initiative with plans to sustain and further increase our investment according to our strategic vision in anticipation of the [artificial superintelligence] era.”U.S.-listed shares of Alibaba have gained over 95% this year.1 Yuan = $0.14For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/bitfarms-slides-after-rallying-to-near-4-year-high-on-300-million-offering/ch6pbe9R3nP">Bitfarms Slides After Rallying To Near 4-Year High On $300 Million Offering, Retail Buzz Stays Elevated</a>

The logo of Alibaba Group is displayed on a smartphone screen. (Photo illustration by Cheng Xin/Getty Images)

Alibaba Executive Reportedly Says Firm Beginning To See Return On AI Investment In E-Commerce: Expects ‘Very Significant’ Positive Impact

According to a CNBC report, Vice President Kaifu Zhang said initial testing has shown that AI has generated steady results with a 12% rise in advertising spend returns.

Amazon store is seen at Promenade Street in Davos, Switzerland on January 21, 2025. (Photo by Ömer Sercan Karku/Anadolu via Getty Images)

Amazon Stock Sees Retail Chatter Surge 39% Amid HR Downsizing News

Meanwhile, Outfront Media, a provider of out-of-home advertising, has announced a strategic partnership with Amazon Web Services to modernize out-of-home planning and buying through AI-enabled workflows.

Eli Lilly and Company (LLY) on Wednesday said that its oral GLP-1 drug Orforglipron lowered blood glucose levels in two late-stage trials, confirming its potential in treating type-2 diabetes.While one of the trials evaluated Orforglipron versus Dapagliflozin in 962 patients with type-2 diabetes inadequately controlled on Metformin, the other trial assessed Orforglipron versus placebo in 546 adults with type 2 diabetes and inadequate glycemic control with titrated insulin glargine.In both <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://lilly.mediaroom.com/2025-10-15-Lillys-oral-GLP-1,-orforglipron,-demonstrated-superior-glycemic-control-in-two-successful-Phase-3-trials,-reconfirming-its-potential-as-a-foundational-treatment-in-type-2-diabetes?utm_source=x&amp;utm_medium=organic&amp;utm_campaign=cmh_offx&amp;utm_id=cmh">trials</a>, all three doses of Orforglipron delivered significant blood sugar reduction and weight loss as well as improvements in multiple cardiovascular risk factors, the company said. While Orforglipron lowered blood sugar levels by up to 1.7% compared to 0.8% with Dapagliflozin in one trial, in the other, it lowered blood sugar by an additional 2.1% when taken with insulin glargine.In both trials, the overall safety and tolerability profile of orforglipron, as well as treatment discontinuation rates, were consistent with previous studies, Lilly said. The results of these trials will now be presented at a future medical meeting."Orforglipron has now demonstrated superiority over two active comparators in clinical trials for type 2 diabetes," said Jeff Emmick, senior vice president of product development, Lilly Cardiometabolic Health. The executive was referring to <a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-says-its-obesity-pill-topped-novo-nordisks-oral-drug-in-late-stage-diabetes-trial/chDGpSDRd6X">data</a> from another late-stage trial where Orforglipron was found to be superior to Novo Nordisk’s oral Semaglutide in treating type-2 diabetes. Emmick noted that these late-stage trial data reinforce the drug’s potential to become a new standard of care for people with type 2 diabetes.The company is now awaiting data from another late-stage trial of Orforglipron in type-2 diabetes in the first quarter of 2026.Lilly plans to submit Orforglipron for the treatment of type 2 diabetes to global regulatory agencies in 2026. Submission for the treatment of obesity is on track to occur by the end of this year, it noted.Orforglipron was discovered by Chugai Pharmaceutical Co. and licensed by Lilly in 2018. Lilly is also studying the drug as a potential treatment for obstructive sleep apnea (OSA) and hypertension in adults with obesity.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/LLY">LLY stock</a> stayed within the ‘bearish’ territory over the past 24 hours, while message volume remained at ‘low’ levels.<figure class="image"><img style="aspect-ratio:590/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_15_at_8_58_15_AM_png_d131a03bfe.webp" alt="LLY's Sentiment Meter and Message Volume as of 8:59 a.m. ET on Oct. 15, 2025 | Source: Stocktwits" width="590" height="64"><figcaption>LLY's Sentiment Meter and Message Volume as of 8:59 a.m. ET on Oct. 15, 2025 | Source: Stocktwits</figcaption></figure>LLY stock is up by 5% this year but down by about 11% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/omeros-corp-stock-soars-pre-market-after-novo-nordisk-agrees-to-buy-its-drug-candidate/ch6nwUGR3NS">Omeros Corp Stock Soars A Whopping 136% Pre-Market After Novo Nordisk Agrees To Buy Its Drug Candidate For Blood Disorder</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The entrance to the Eli Lilly factory in Kinsale, Co Cork, where weight loss drug Mounjaro is made. Picture date: Sunday May 18, 2025.

Eli Lilly Says Oral GLP-1 Drug Reduced Blood Sugar Levels In Two Late-Stage Trials

Eli Lilly plans to submit Orforglipron for the treatment of type 2 diabetes to global regulatory agencies in 2026.

Johnson &amp; Johnson (JNJ) on Tuesday announced its intent to separate its Orthopedic business.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-intent-to-separate-its-orthopaedics-business">said</a> that it will explore multiple paths to separate the business and is targeting a completion in 18 to 24 months. There can be no assurance regarding the absolute timing or structure of the proposed separation, the company stated, while adding that there can be no assurance that the transaction will be completed.The transaction, if completed, would establish a standalone orthopedics business, operating as DePuy Synthes. The company expects the transaction to increase its top-line growth and operating margins by focusing on other growth areas, such as oncology and immunology.<a href="https://stocktwits.com/symbol/JNJ">JNJ stock</a> traded nearly 1% higher in the pre-market session at the time of writing. On Stocktwits, retail sentiment around JNJ stock rose from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.“The planned separation reflects our long-standing commitment to portfolio optimization and value creation. We are confident that our Orthopedics business will be better positioned to improve top-line growth and operating margins as a standalone business,” CEO Joaquin Duato said. For fiscal year 2024, the Orthopedics business generated approximately $9.2 billion in sales.Johnson also appointed Namal Nawana as Worldwide President of DePuy Synthes to lead the business through the separation process. Nawana will report directly to the CEO and is expected to lead DePuy Synthes following the completion of the separation. Nawana was previously Executive Chairman and Founder of privately-held Sapphiros.Until separation, Johnson said that it will continue to operate the business in alignment with its current strategy, including continued investments.The announcement comes on the heels of the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q3-2025-results-raises-2025-sales-outlook">reporting</a> a third-quarter (Q3) reported sales growth of 6.8% to $23.99 billion, beating an analyst estimate of $23.73 billion. The firm also reported an adjusted and diluted earnings per share (EPS) of $2.80, above the expected $2.76.Johnson &amp; Johnson also raised its full-year estimated reported sales guidance to a range of $93.0 billion to $93.4 billion, up from its previous guidance of $92.7 billion to $93.1 billion, and reaffirmed its full-year adjusted EPS guidance of $10.80 to $10.90.JNJ stock is up by 32% this week and by about 18% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wells-fargo-appoints-ceo-charlie-scharf-as-chairman-after-q3-earnings-beat-estimates/ch6mVM6R3mE">Wells Fargo Appoints CEO Charlie Scharf As Chairman After Q3 Earnings Beat Estimates</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 Johnson and Johnson American multinational of medical, pharmaceutical and perfumery products headquartes on 28 January 2025 in Madrid, Spain.

Johnson & Johnson To Separate Its Orthopedic Business

The company said that it will explore multiple paths to separate the business and is targeting a completion in 18 to 24 months.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Active Growth ETF

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

JGRO
JPMorgan Active Growth ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest JGRO News

JGROJPMorgan Active Growth ETF